[Continuous flow vasodilator perfusion treatment in the acute phase of myocardial infarct].
D000208:Acute Disease; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D005292:Ferricyanides / Q000008:administration & dosage*; D006801:Humans; D007263:Infusions, Parenteral; D009200:Myocardial Contraction / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy*; D009599:Nitroprusside / Q000008:administration & dosage* / Q000494:pharmacology; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000494:pharmacology
D005292:Ferricyanides; D014665:Vasodilator Agents; D009599:Nitroprusside
Traitement vasodilatateur en perfusion à débit constant à la phase aiguë de l'infarctus du myocarde.